{"result": {"id": "18dc7fe9-f159-48d5-8cee-6cb5ee7d7c6e", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**吉非罗齐（Gemfibrozil）**是一种贝特类药物，主要用于治疗以三酰甘油（甘油三酯）升高为主的高脂血症，可有效降低血液中的三酰甘油水平。作为降脂药物，吉非罗齐通过调节脂质代谢发挥作用，常用于临床管理高脂血症患者。  \n\n然而，吉非罗齐可能与其他药物发生显著的相互作用，尤其是与他汀类药物（如辛伐他汀、阿托伐他汀）合用时。研究表明，吉非罗齐可增加辛伐他汀的AUC（血药浓度-时间曲线下面积）和Cmax（峰值浓度），从而升高肌肉毒性风险，如肌酸激酶（CK）升高和肌病。此外，吉非罗齐通过抑制UGT（尿苷二磷酸葡萄糖醛酸转移酶）介导的代谢，延缓阿托伐他汀的葡萄糖醛酸化过程，进一步增加其AUC，加剧肌病风险。  \n\n吉非罗齐的代谢途径涉及UGT，其代谢产物还可抑制CYP2C8酶活性，从而影响经CYP2C8代谢的药物（如罗格列酮、瑞格列奈）的药代动力学，可能导致这些药物的血药浓度升高，增加不良反应风险。因此，联合用药时需谨慎监测，必要时调整剂量以避免潜在的药物相互作用。  \n\n综上所述，吉非罗齐是一种有效的降三酰甘油药物，但因其显著的药物相互作用特性，临床使用时应特别注意与他汀类及CYP2C8底物药物的联用风险，以确保用药安全性。", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1753517961, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 328, "prompt_tokens": 335, "total_tokens": 663, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 64}, "prompt_cache_hit_tokens": 64, "prompt_cache_miss_tokens": 271}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or more entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\nLimit the final description length to 500 words.\n\n#######\n-Data-\nEntities: \"吉非罗齐\"\nDescription List: [\"A fibrate drug used to lower triglycerides, also known as Gemfibrozil\\\"\", \"吉非罗齐是一种药物，与辛伐他汀合用会增加辛伐他汀的AUC和Cmax，可能导致肌肉毒性\", \"吉非罗齐是一种药物，可导致肌酸激酶升高和肌病，并抑制UGT减慢阿托伐他汀的葡萄糖醛酸化代谢>\", \"吉非罗齐是一种药物，能使阿托伐他汀的AUC增加，增加肌病风险。\\\"\", \"吉非罗齐是一种贝特类药物，用于以三酰甘油升高为主的高脂血症。\", \"吉非罗齐是一种贝特类药物，用于降低三酰甘油水平\", \"吉非罗齐是一种贝特类药物，经UGT代谢后可抑制CYP2C8，与其他经CYP2C8代谢的药物（如罗格列酮、瑞格列奈）产生相互作用>\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_6d6bf9077048b67bcf2f30a494c6dac5d4589e6ce1f999e54c59e5830421fd29_v2"}